RG
Redmile Group Portfolio holdings
AUM
$940M
This Quarter Return
-16.16%
1 Year Return
+75.78%
3 Year Return
+543.67%
5 Year Return
+585.96%
10 Year Return
+6,653.82%
AUM
$1.06B
AUM Growth
+$1.06B
(-26%)
Cap. Flow
-$58.2M
Cap. Flow
% of AUM
-5.5%
Top 10 Holdings %
Top 10 Hldgs %
61.75%
Holding
64
New
2
Increased
7
Reduced
32
Closed
8
Top Buys
| 1 |
Amicus Therapeutics
FOLD
|
$20.2M |
| 2 |
iRhythm Technologies
IRTC
|
$5.95M |
| 3 |
Solid Biosciences
SLDB
|
$5.19M |
| 4 |
Insulet
PODD
|
$4.61M |
| 5 |
Masimo
MASI
|
$4.34M |
Top Sells
| 1 |
Boston Scientific
BSX
|
$12M |
| 2 |
Akero Therapeutics
AKRO
|
$12M |
| 3 |
Stryker
SYK
|
$11M |
| 4 |
Intuitive Surgical
ISRG
|
$8.84M |
| 5 |
Ardelyx
ARDX
|
$7.99M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Immunovant
IMVT
$2.91B
| $8.38M | 0.79% |
490,394
-81,430
| -14% | -$1.39M |
|
|
CBLL
27
CeriBell, Inc. Common Stock
CBLL
$426M
| $8.36M | 0.79% |
435,239
| – | – |
|
28
RAPT Therapeutics
RAPT
$187M
| $7.9M | 0.75% |
6,475,317
| – | – |
|
|
29
Solid Biosciences
SLDB
$448M
| $7.47M | 0.71% |
2,019,171
+1,403,925
| +228% | +$5.19M |
|
|
30
Insulet
PODD
$24.2B
| $7.12M | 0.67% |
27,109
+17,550
| +184% | +$4.61M |
|
31
BioNTech
BNTX
$24.1B
| $6.65M | 0.63% |
73,071
-10,400
| -12% | -$947K |
|
|
SLN
32
Silence Therapeutics
SLN
$237M
| $6.25M | 0.59% |
2,214,947
-184,370
| -8% | -$520K |
|
33
Penumbra
PEN
$10.5B
| $6.11M | 0.58% |
22,843
-2,900
| -11% | -$775K |
|
|
34
iRhythm Technologies
IRTC
$5.67B
| $5.95M | 0.56% |
+56,844
| New | +$5.95M |
|
35
Keros Therapeutics
KROS
$640M
| $5.63M | 0.53% |
552,506
| – | – |
|
|
VERV
36
DELISTED
Verve Therapeutics
VERV
| $5.52M | 0.52% |
1,207,164
-111,000
| -8% | -$507K |
|
37
Nuvation Bio
NUVB
$1.08B
| $5.33M | 0.5% |
3,031,009
| – | – |
|
38
Shattuck Labs
STTK
$61.3M
| $5.26M | 0.5% |
5,539,724
| – | – |
|
|
39
Masimo
MASI
$7.43B
| $4.34M | 0.41% |
+26,062
| New | +$4.34M |
|
40
Prime Medicine
PRME
$595M
| $4.13M | 0.39% |
2,074,350
| – | – |
|
|
ORKA
41
Oruka Therapeutics, Inc. Common Stock
ORKA
$578M
| $3.97M | 0.38% |
386,963
-24,765
| -6% | -$254K |
|
|
IGMS
42
DELISTED
IGM Biosciences
IGMS
| $3.39M | 0.32% |
2,952,131
| – | – |
|
43
Cytokinetics
CYTK
$5.98B
| $3.3M | 0.31% |
82,098
-10,500
| -11% | -$422K |
|
44
4D Molecular Therapeutics
FDMT
$302M
| $3.22M | 0.3% |
997,235
-199,675
| -17% | -$645K |
|
45
Pliant Therapeutics
PLRX
$105M
| $2.77M | 0.26% |
2,053,559
-841,919
| -29% | -$1.14M |
|
46
LAVA Therapeutics
LVTX
$41.3M
| $2.63M | 0.25% |
2,074,372
| – | – |
|
47
Atara Biotherapeutics
ATRA
$88.7M
| $2.62M | 0.25% |
441,701
| – | – |
|
48
Xeris Biopharma Holdings
XERS
$1.27B
| $2.48M | 0.23% |
451,099
| – | – |
|
49
ALX Oncology
ALXO
$54.6M
| $2.27M | 0.21% |
3,640,834
-48,777
| -1% | -$30.4K |
|
50
Repare Therapeutics
RPTX
$73.9M
| $1.86M | 0.18% |
1,884,389
-31,700
| -2% | -$31.3K |
|